Natera Inc (NTRA)
Industry Diagnostics & Research
This stock can be held in an Investment ISA and an Investment Account
Sell
$223.92
Buy
$226.80
$-1.91 (-0.84%)
Prices updated at 17 Dec 2025, 23:49 EST
| Prices minimum 15 mins delay
Prices in USD
Natera Inc is a provider of diagnostic services predominantly in the United States. It offers various tests which detect chromosomal abnormalities, reasons for miscarriages and paternity.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 60.30 |
| 2023 | 45.52 |
| 2022 | 44.37 |
| 2021 | 49.09 |
| 2020 | 47.92 |
| 2019 | 41.96 |
| 2018 | 35.55 |
| 2017 | 33.41 |
| 2016 | 36.20 |
| 2015 | 40.72 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 14.50 |
| 2024 | 12.57 |
| 2023 | 7.05 |
| 2022 | 4.97 |
| 2021 | 14.60 |
| 2020 | 21.65 |
| 2019 | 7.76 |
| 2018 | 3.21 |
| 2017 | 2.30 |
| 2016 | 2.69 |
| 2015 | 2.88 |
Price/Forward earnings (YTD)
-217.39
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | -12.28 |
| 2023 | -30.66 |
| 2022 | -41.64 |
| 2021 | -43.50 |
| 2020 | -30.33 |
| 2019 | -29.34 |
| 2018 | -53.09 |
| 2017 | -64.72 |
| 2016 | -42.16 |
| 2015 | -36.14 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 1.39 |
| 2023 | 1.88 |
| 2022 | 1.98 |
| 2021 | 1.89 |
| 2020 | 1.92 |
| 2019 | 2.09 |
| 2018 | 8.34 |
| 2017 | 8.44 |
| 2016 | 1.98 |
| 2015 | 1.44 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
